TW266159B - - Google Patents

Info

Publication number
TW266159B
TW266159B TW083102550A TW83102550A TW266159B TW 266159 B TW266159 B TW 266159B TW 083102550 A TW083102550 A TW 083102550A TW 83102550 A TW83102550 A TW 83102550A TW 266159 B TW266159 B TW 266159B
Authority
TW
Taiwan
Prior art keywords
pct
active ingredient
weight
release
tablet
Prior art date
Application number
TW083102550A
Other languages
English (en)
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6484646&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW266159(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Knoll Ag filed Critical Knoll Ag
Application granted granted Critical
Publication of TW266159B publication Critical patent/TW266159B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
TW083102550A 1993-04-03 1994-03-23 TW266159B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4310963A DE4310963C2 (de) 1993-04-03 1993-04-03 Retardmikrotablette von beta-Phenylpropiophenonderivaten

Publications (1)

Publication Number Publication Date
TW266159B true TW266159B (zh) 1995-12-21

Family

ID=6484646

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083102550A TW266159B (zh) 1993-04-03 1994-03-23

Country Status (28)

Country Link
US (1) US5681588A (zh)
EP (1) EP0691843B1 (zh)
JP (1) JP3625825B2 (zh)
KR (1) KR100315618B1 (zh)
CN (1) CN1092957C (zh)
AT (1) ATE148988T1 (zh)
AU (1) AU678227B2 (zh)
BR (2) BR9406036A (zh)
CA (1) CA2158166C (zh)
CZ (1) CZ284869B6 (zh)
DE (2) DE4310963C2 (zh)
DK (1) DK0691843T3 (zh)
ES (1) ES2098930T3 (zh)
FI (1) FI114610B (zh)
GR (1) GR3023339T3 (zh)
HR (1) HRP940198B1 (zh)
HU (1) HU221590B (zh)
IL (2) IL109097A0 (zh)
NO (1) NO306848B1 (zh)
NZ (1) NZ263565A (zh)
PL (1) PL175219B1 (zh)
RU (1) RU2157191C2 (zh)
SG (1) SG43955A1 (zh)
SI (1) SI9420027A (zh)
TW (1) TW266159B (zh)
UA (1) UA40616C2 (zh)
WO (1) WO1994022434A1 (zh)
ZA (1) ZA942293B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
JP4331930B2 (ja) * 2001-10-17 2009-09-16 武田薬品工業株式会社 酸に不安定な薬物の高含量顆粒
US20050226923A1 (en) * 2004-04-07 2005-10-13 Gassert Chad M Venlafaxine compositions in the form of microtablets
CA2469327A1 (en) * 2004-06-07 2005-12-07 Bernard Charles Sherman Propafenone hydrochloride capsules containing microtablets
CA2469339A1 (en) * 2004-06-07 2005-12-07 Bernard Charles Sherman Sustained release propafenone hydrochloride capsules
DE102006006532B4 (de) * 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
WO2007103557A2 (en) 2006-03-09 2007-09-13 Reliant Pharmaceuticals, Inc. Coating capsules with active pharmaceutical ingredients
US20080014257A1 (en) * 2006-07-14 2008-01-17 Par Pharmaceutical, Inc. Oral dosage forms
US20090035370A1 (en) * 2007-08-02 2009-02-05 Drugtech Corporation Dosage form and method of use
WO2010043950A2 (en) 2008-10-15 2010-04-22 Aizant Drug Research Solutions Private Limited Propafenone extended release composition
CN103908443A (zh) * 2013-11-25 2014-07-09 力品药业（厦门）有限公司 一种盐酸普罗帕酮缓释胶囊及其制备方法
CN107441051B (zh) * 2016-05-30 2022-09-16 北京科信必成医药科技发展有限公司 一种盐酸普罗帕酮微片及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951821A (en) * 1972-07-14 1976-04-20 The Dow Chemical Company Disintegrating agent for tablets
DE3210061A1 (de) * 1982-03-19 1983-09-22 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von propafenon
DE3422619A1 (de) * 1984-06-19 1985-12-19 Basf Ag, 6700 Ludwigshafen Zylindrische mikrotabletten
GB2176999B (en) * 1985-06-22 1989-07-12 Stanley Stewart Davis Sustained release medicament
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
DE3725273A1 (de) * 1987-07-30 1989-02-09 Basf Ag Verfahren zur synthese von enantiomeren des propafenons sowie diese enthaltende therapeutische mittel
DE3809764A1 (de) * 1988-03-23 1989-10-05 Knoll Ag Mischung aus alginaten und polyacrylaten und deren verwendung
US4954347A (en) * 1988-05-03 1990-09-04 Basf K & F Corp. Long lasting composition of propafenone and quinidine for treatment of cardiac conditions
DE3911069A1 (de) * 1989-04-06 1990-10-11 Knoll Ag Einkristalle von ss-phenylpropiophenonen
CA2085231C (en) * 1990-07-02 1997-12-30 Berthold Stemmle Process for the preparation of shaped, compressed controlled-release unit-dosage forms, and the compressed unit-dosage forms thus obtained
DE4021678C2 (de) * 1990-07-07 1994-07-07 Merz & Co Gmbh & Co Verfahren zur Herstellung klein dimensionierter Formkörper mit hohem Etofibrat-Gehalt und kontrollierter Wirkstoff-Freisetzung, deren Verwendung und daraus bestehende oral verabreichbare Applikationsformen
IT1250483B (it) * 1990-08-30 1995-04-07 Eurand Int Sistema di ritardo a matrice multipla

Also Published As

Publication number Publication date
KR100315618B1 (ko) 2002-02-28
HU9502879D0 (en) 1995-11-28
SI9420027A (en) 1996-08-31
DK0691843T3 (da) 1997-04-28
EP0691843A1 (de) 1996-01-17
HUT73248A (en) 1996-07-29
ATE148988T1 (de) 1997-03-15
DE4310963A1 (de) 1994-10-06
CN1120312A (zh) 1996-04-10
ES2098930T3 (es) 1997-05-01
PL175219B1 (pl) 1998-11-30
PL310966A1 (en) 1996-01-22
IL109097A (en) 1998-09-24
GR3023339T3 (en) 1997-08-29
ZA942293B (en) 1995-10-02
HRP940198B1 (en) 1997-12-31
CZ284869B6 (cs) 1999-03-17
NO953910D0 (no) 1995-10-02
CZ246595A3 (en) 1996-02-14
UA40616C2 (uk) 2001-08-15
WO1994022434A1 (de) 1994-10-13
EP0691843B1 (de) 1997-02-19
DE59401833D1 (de) 1997-03-27
KR960701630A (ko) 1996-03-28
FI114610B (fi) 2004-11-30
DE4310963C2 (de) 1997-06-05
JPH08508010A (ja) 1996-08-27
CA2158166C (en) 2003-10-21
BR9406036A (pt) 1995-12-12
JP3625825B2 (ja) 2005-03-02
CA2158166A1 (en) 1994-10-13
IL109097A0 (en) 1994-06-24
CN1092957C (zh) 2002-10-23
HU221590B (hu) 2002-11-28
RU2157191C2 (ru) 2000-10-10
AU678227B2 (en) 1997-05-22
NZ263565A (en) 1996-08-27
FI954686A0 (fi) 1995-10-02
SG43955A1 (en) 1997-11-14
HRP940198A2 (en) 1996-10-31
US5681588A (en) 1997-10-28
NO306848B1 (no) 2000-01-03
FI954686A (fi) 1995-10-02
NO953910L (no) 1995-10-02
BR1100303A (pt) 2002-04-02
AU6429594A (en) 1994-10-24

Similar Documents

Publication Publication Date Title
TW266159B (zh)
EP0249347A3 (en) Controlled release dihydrocodeine composition
GR3025550T3 (en) Extended release, film-coated tablet of astemizole and pseudoephedrine
MD872G2 (ro) Compoziţie farmaceutică efervescentă şi preparat pe baza ei, procedeu de fabricare a preparatului
GB2196848B (en) Controlled release hydromorphone composition
MY139606A (en) Sustained-release composition and process for producing the same
AU6388994A (en) Composition for oral administration of peptides
US5082665A (en) Anti-snoring formulations using yohimbine
AU5784096A (en) Method and composition for prevention of posterior capsule opacification
PL317996A1 (en) Carbamazepinic form of a drug with retarded release of biologically active substance
CA2437412A1 (en) Delayed release microtablet of b-phenylpropiophenone derivatives
CA2012257A1 (en) Anti-snoring formulations
YU20050410A (sh) Kompozicije oksikodona sa kontrolisanim oslobađanjem
AU2417192A (en) Rapidly disintegratable multiparticulate tablet

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent